New Arthrys clinical report

We are releasing a preliminary report of our Arthrys post-market clinical follow-up (PMCF). We are grateful to Dr. Federico Valli, orthopaedic surgeon in Milan, for his collaboration.

This PMCF activity was performed on osteoarthritis patients treated with one shot of Arthrys 5mg/ml, showing its safety and effectiveness in ameliorating pain and functionality symptoms.

The report is available for direct download here or on Arthrys portfolio page.